Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Mol Pathol ; 104(2): 155-157, 2018 04.
Article in English | MEDLINE | ID: mdl-29452080

ABSTRACT

A 40 year old female with no documented medical history presented to the Emergency Department with several days of lethargy and altered mental status. She was found to be anemic, thrombocytopenic, and hypotensive. The patient was found to be in severe metabolic acidosis, became bradycardic, and quickly deteriorated. Clinicians suspected thrombotic thrombocytopenic purpura, and the diagnosis was supported by ADAMTS13 testing. The clinicians attempted to place a Quinton catheter for emergent plasmapheresis, but the patient expired before definitive treatment could be initiated. Autopsy was obtained and revealed a right middle lobe consolidation grossly consistent with lymphoid tissue or tumor.


Subject(s)
Lung Neoplasms/pathology , Lymphoma, B-Cell, Marginal Zone/pathology , ADAMTS13 Protein/blood , Adult , Autopsy , Female , Humans , Purpura, Thrombotic Thrombocytopenic/diagnosis
2.
Exp Mol Pathol ; 101(2): 197-200, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27544027

ABSTRACT

Acute promyelocytic leukemia (APL) with t(15;17)(q22;q21)/PML-RARα is a subtype of acute myeloid leukemia (AML) with distinct morphologic and immunophenotypic characteristics. It is a highly aggressive disease that requires rapid diagnosis and early intervention. In addition to morphologic evaluation, flow cytometry has been widely used to facilitate prompt diagnosis of this disease. Compared with other types of AML, APL typically displays a triad of absent or weak CD34, absent HLA-DR, and positive CD117. HLA-DR positive APL is extremely rare and its clinical and pathological features have not been reported. A total of 45 cases of APL with t(15,17)/PML-RARα were diagnosed at Harbor-UCLA Medical Center from year 2006 to 2015. Among them, only two cases were positive for HLA-DR by flow cytometry immunophenotyping. Here we describe the clinical, morphologic, immunophenotypic, and cytogenetic features of these two cases.


Subject(s)
HLA-DR Antigens/immunology , Leukemia, Promyelocytic, Acute/immunology , Blast Crisis/pathology , Female , Flow Cytometry , Humans , Immunophenotyping , Leukemia, Promyelocytic, Acute/blood , Middle Aged , Young Adult
3.
Exp Mol Pathol ; 98(2): 300-3, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25708661

ABSTRACT

Low-grade fibromyxoid sarcoma (LGFMS) is a rare soft tissue tumor with a slight male predominance. The tumor has a tendency to arise from deep soft tissue of the trunk and lower extremities. Rare cases are reported to arise from the mediastinal and retroperitoneal areas. Its deceptively bland histologic appearance makes this tumor difficult to diagnose. Also, there are several histologic mimics that may hinder in its diagnosis. We report a case of low-grade fibromyxoid sarcoma from a 48-year-old woman, first documented herein to arise from the sigmoid. We also report the value of CD99, BCL2 and MUC4 stains in the diagnosis of this tumor.


Subject(s)
Fibroma/diagnosis , Sigmoid Neoplasms/diagnosis , Soft Tissue Neoplasms/diagnosis , 12E7 Antigen , Antigens, CD/analysis , Cell Adhesion Molecules/analysis , Colon, Sigmoid/pathology , Colon, Sigmoid/surgery , Female , Fibroma/diagnostic imaging , Fibroma/surgery , Humans , Middle Aged , Mucin-4/analysis , Proto-Oncogene Proteins c-bcl-2/analysis , Radiography , Sigmoid Neoplasms/diagnostic imaging , Sigmoid Neoplasms/surgery , Soft Tissue Neoplasms/diagnostic imaging , Soft Tissue Neoplasms/surgery , Staining and Labeling
4.
Exp Mol Pathol ; 98(1): 65-72, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25526666

ABSTRACT

Efficient management of misfolded or aggregated proteins in ASH and NASH is crucial for continued hepatic viability. Cellular protein quality control systems play an important role in the pathogenesis and progression of ASH and NASH. In a recent study, elevated Mca1 expression counteracted aggregation and accumulation of misfolded proteins and extended the life span of the yeast Saccharomyces cerevisiae (Hill et al, 2014). Mca1 may also associate with Ssa1 and Hsp104 in disaggregation and fragmentation of aggregated proteins and their subsequent degradation through the ER-associated degradation (ERAD) pathway. If degradation is not available, protection of the cellular environment from a misfolded protein is accomplished by its sequestration into two distinct inclusion bodies (Kaganovich et al., 2008) called the JUNQ (JUxta Nuclear Quality control compartment) and the IPOD (Insoluble Protein Deposit). Mca1, Hsp104, Hsp40, Ydj1, Ssa1, VCP/p97, and p62 all play important roles in protein quality control systems. This study aims to measure the expression of Mca1 and related chaperones involved in protein quality control in alcoholic steatohepatitis (ASH), and nonalcoholic steatohepatitis (NASH) compared with normal control liver biopsies. Mca1, Hsp104, Hsp40, Ydj1, Ssa1, VCP/p97, and p62 expressions were measured in three to six formalin-fixed paraffin embedded ASH and NASH liver biopsies and control normal liver specimens by immunofluorescence staining and quantified by immunofluorescence intensity. Mca1, Hsp104, Ydj1 and p62 were significantly upregulated compared to control (p<0.05) in ASH specimens. Hsp40 and VCP/p97 were also uptrending in ASH. In NASH, the only significant difference was the increased expression of Hsp104 compared to control (p<0.05). Ssa1 levels were uptrending in both ASH and NASH specimens. The upregulation of Mca1, Hsp104, Ydj1 and p62 in ASH may be elicited as a response to the chronic exposure of the hepatocytes to the toxicity of alcohol. Recruitment of Mca1, Hsp104, Ydj1 and p62 may indicate that autophagy, the ERAD, JUNQ, and IPOD systems are active in ASH. Whereas in NASH, elevated Hsp104 and uptrending Ssa1 levels may indicate that autophagy and IPOD may be the only active protein quality control systems involved.


Subject(s)
Biomarkers/metabolism , Caspases/metabolism , Fatty Liver, Alcoholic/metabolism , Gene Expression Regulation , Molecular Chaperones/metabolism , Non-alcoholic Fatty Liver Disease/metabolism , Autophagy , Endoplasmic Reticulum-Associated Degradation , Fatty Liver, Alcoholic/pathology , Fluorescent Antibody Technique , Humans , Liver/metabolism , Non-alcoholic Fatty Liver Disease/pathology , Protein Folding , Proteolysis
SELECTION OF CITATIONS
SEARCH DETAIL
...